Synapse News
Ontario Together Fund Supports NERv Technology’s Domestic Manufacturing
hrough the Ontario Together Fund, the Ontario provincial government has committed $559,200 to support the domestic manufacturing and commercialization of NERv Technology’s breakthrough post-operative monitoring solutions as part of the company’s $1.118 million investment. NERv Technology Inc. is a Kitchener-based medical device…
Two Hamilton innovators win national Arthritis Ideator Awards
Two Hamiltonians were among 4 winners (and eight finalists) in a national competition which provides funding for innovative projects that help people suffering from arthritis. The Arthritis Ideator Program — run by the Arthritis Society — received 21 submissions from innovators, entrepreneurs, and startups across Canada working on…
McMaster Seed Fund supports two startups in first round of funding with $735,000
Two McMaster startups – Syndemix and Insight Medbotics – have received a combined $735,000 to move their innovations closer to reality in the first round of investments of the McMaster Seed Fund. Synmedix — a biotechnology company founded by Eric Brown, Distinguished University Professor of biochemistry and biomedical sciences —…
Ontario invests $40 million to grow global life sciences sector at Hamilton’s McMaster Innovation Park
Hamilton could become the “catalyst” that will see Ontario become a global hub for biomanufacturing and life sciences growth. Invest Ontario is providing OmniaBio Inc. with about $40 million in a loan as part of a new $580-million biomanufacturing facility at McMaster Innovation Park on Longwood Road. The goal for the Ontario government…
Ontario economic development minister Announces $40M investment in Hamilton’s OmniaBio (video)
Vic Fedeli, Minister of Economic Development, Job Creation and Trade, was joined by Prabmeet Sarkaria, President of the Treasury Board, and Donna Skelly, MPP for Flamborough—Glanbrook, to make an announcement at McMaster Innovation Park
Invest Ontario Supports New Biomanufacturing Facility in Hamilton
Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancer, cardiovascular diseases, Parkinson’s and diabetes. OmniaBio, a Canadian cell and gene…
New gene- and cell-therapy manufacturing facility to launch in Hamilton with $580-million commitment
Ontario says it will provide a $40-million loan to the Centre for Commercialization of Regenerative Medicine for its planned $580-million Hamilton facility where life-science companies can develop and commercialize cell and gene therapies. The CCRM, a non-profit industry group, said Thursday that the facility will be run by a new subsidiary…
Triumvira Immunologics Completes Extension of Series A Financing, for Total Round of Approximately $100 Million
Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced the completion of an extension of its Series A financing, bringing the total round to approximately $100 million. The Series A…
Dr. Marc Jeschke named new VP of Research at HHS
Hamilton Health Sciences Centre has announced the appointment of Dr. Marc Jeschke (pictured) as vice president of research at HHS, commencing on June 1, 2022. Dr. Jeschke brings world-renowned expertise to the organization in the field of translational research through which basic scientific and medical research are brought into day-to-day…